Scientists launch Long-Term study to unravel rare spinal disease caused by a virus
NCT ID NCT00001778
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 7 times
Summary
This study follows people infected with HTLV-I virus, some of whom develop a rare spinal cord condition called HAM/TSP. Researchers will track changes in symptoms, immune system markers, and virus levels over time. The goal is to better understand why only a few infected people get the disease and how it progresses. No new treatments are being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how HTLV-I leads to spinal cord damage, pointing toward future treatments or monitoring strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve symptoms, and findings may take years to translate into therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HTLV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States